Kaleido Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Kaleido Biosciences

11/08/2021 14:02

* Kaleido Biosciences Inc  KLDO.OQ  reported a quarterly
adjusted loss of 56 cents​​ per share for the quarter ended in
June. The mean expectation of seven analysts for the quarter was
for a loss of 57 cents per share.
* Revenue fell 15.6% to $211.00 thousand from a year ago; 
analysts expected $110.00 thousand. 
* Kaleido Biosciences Inc's reported EPS for the quarter was a
loss of 56 cents​.
* The mean earnings estimate of analysts had fallen by
about 0.2% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Kaleido Biosciences Inc shares had fallen by 19.4% this
quarter and lost 34.1% so far this year.
* The company reported a quarterly loss of $23.89 million.
* Wall Street's median 12-month price target for Kaleido
Biosciences Inc is $17.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated August 11 at 01:02 p.m.  ​All
figures in US dollars unless otherwise stated